Direct equity investment Opportunity

Please enter your details to request more information

15%

Annual Returns plus 5% Profit bonus

FIXED DIVIDEND

Medicinal Cannabis in Europe has a compound annual growth rate (cagr) of 67.4%

Orange River Capital have a proven track record of creating solid returns for our investors. Our profitable medicinal cannabis cultivation facility produces high grade medicinal cannabis and cannabis concentrates. We are now expanding our operations across Europe in 2024 to create a global network with international market access.

• 15% fixed annual return from year 1
• Up to 5% additional profit related profit bonus from year 2
• Direct equity ownership- share certificates
• First dividend payment date will be 31 January 2024
• Minimum Investment $25,000 USD

Analysts calculate that the annual number of medicinal cannabis products prescribed during 2022 amounts to a 90% year on year increase.

Top Conditions that a Doctor can prescribe Medicinal Cannabis for:

Multiple sclerosis Cancer pain Alzheimer’s disease and dementia, Parkinson’s disease, Crohn’s disease, depression, chronic pain and glaucoma

In the press

Disclaimer: Any person accessing the website and considering potential investment opportunities featured on the website should make their own commercial assessment and could benefit from the advice of an appropriately authorised or regulated financial advisor. This website should not be construed as advice or a personal recommendation to any prospective investor. Investments of this nature carry risks to your capital and can go up or down. Past performance is not indicative of future results.